Intra-Cellular Therapies Overview

Intra-Cellular Therapies Other Income Expense Net

Other Income/Expense Net for ITCI.

Quarterly Other Income/Expense

$11.99M

↑ 101.06% YoY

As of Dec 31, 2024

Annual Other Income/Expense (TTM)

$42.52M

↑ 109.01% YoY

Trailing 12 months ending Dec 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin